About this event
- Date and time Wed 4 Mar 2020 from 9:30am to 4:00pm
- Location Royal Society of Medicine
The RSM is dedicating an entire day to the in-depth understanding of genetic causes, identification and management of Familial Hypercholesterolaemia (FH). From this live streamed event, you will have an unprecedented opportunity to learn about this under-diagnosed, potentially fatal, but eminently treatable disorder.
Unfortunately, tickets to attend this event in London have sold out. Please book this free live stream if you would like to update your knowledge on FH.
With a documented prevalence of 1 in 250, FH is now known to be one of the most common genetic diseases, affecting around 220,000 individuals in the UK.
You will be updated on advances in DNA testing in the NHS, the genetics of FH, new recommendations in the NICE 2017 FH guidelines, the new HEARTUK Paediatric FH management guidelines and potential future identification of children and parents with FH by universal screening, electronic note searching for possible FH by GPs, the cost consequences of different case-finding strategies to identify patients with severe FH and of not identifying and managing FH, and of the way clinicians are tackling problems of commissioning the care pathway for FH patients.
Key topics include:
- The NHS long term plan for FH and the proposed London minimum data set
- The key changes to the 2017 NICE update of the identification and management of FH
- The key role of GPs and utility of electronic note searching algorithms to identify possible FH patients for referral
- New advances in the genetic causes of the FH phenotype (monogenic and polygenic) and how this leads to a precision medicine approach for these patients
- The UK and international approaches for universal screening for FH in childhood
- The Statement of Care for management of children with FH
We would like to thank our exhibitors:
Amgen and Sanofi
Please note that none of the companies listed have had any influence or involvement over the agenda, content or organisation of this meeting.
Tickets
Standard pricing available until 03 March 2020.
Member
| RSM Associate | RSM Fellow | RSM Retired Fellow | RSM Student | RSM Trainee |
|---|---|---|---|---|
| £0.00 | £0.00 | £0.00 | £0.00 | £0.00 |
Non - Member
| Student | AHP / Nurse / Midwife | Consultant / GP | Trainee |
|---|---|---|---|
| £0.00 | £0.00 | £0.00 | £0.00 |
Agenda
View the programme
Live stream broadcast begins
Session 1
Chairs: Professor Sean Carroll, Professor Steve Humphries and Dr Jaimini Cegla
Chair’s welcome
The National Health Service long term plan and the pan-London five year ambition for Familial Hypercholesterolemia
Clare Thompson, Senior Project Manager, Cardiac Clinical Network, NHS England and NHS Improvement - London Region
Improving the management of Familial Hypercholesterolemia – the patient experience
Mark Fisher, Patient
The new recommendations in the National Institute for Health and Care Excellence 2017 Familial Hypercholesterolemia guidelines
Dr Jaimini Cegla, Imperial College Healthcare NHS Foundation Trust
Electronic note searching for possible Familial Hypercholesterolemia by general practice using Familial a new case ascertainment tool and other algorithms
Professor Nadeem Qureshi, Clinical Professor of Primary Care, Co-Director, Primary Care Stratified Medicine (PriSM) group, NIHR School of Primary Care Research, University of Nottingham
Panel discussion
A health economic cost consequences analysis of different case finding strategies to identify patients with Familial Hypercholesterolemia
Nick Hex, Associate Director, York Health Economics Consortium Ltd, University of York
Session 2
Chairs: Dr Handrea Soran and Dr Devaki Nair
Update on the genetics of Familial Hypercholesterolemia
Steve Humphries and Marta Futema, University College London
How many DNA-confirmed UK Familial Hypercholesterolemia patients have been found to date?
Kate Haralambos, Project Co-Ordinator, University of Cardiff
Progress and problems in finding Familial Hypercholesterolemia patients in Scotland
Professor Zosia Miedzybrodzka, University of Aberdeen
Panel discussion
Session 3
Chairs: Professor Steve Humphries and Dr Ben Jones
Morbidity data for patients in the Simon Broome Familial Hypercholesterolemia register 1997-2018
Dr Barbara Iyen, National Institute for Health Research Academic Clinical Lecturer in General Practice, University of Nottingham
Child-parent screening for Familial Hypercholesterolaemia
Professor David Wald, Barts Health NHS Trust and the London School of Medicine and Dentistry
Universal screening for high cholesterol in five-year old children – the Slovenian experience
Dr Uhr Groselj, Pediatric Clinic, University of Ljubljana, Slovenia
The new HEART UK pediatric Familial Hypercholesterolemia management guidelines
Dr Uma Ramaswami, Royal Free London NHS Foundation Trust
The FH studies collaboration- global initiatives for Familial Hypercholesterolemia detection and management
Dr Antonio Vallejo-Vaz, Clinical Research Fellow, Imperial College London
General discussion
Close of meeting
Professor Sean Carroll
End of live stream
Sponsors
Location
Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom